A road map to Translational Medicine in Qatar and a model for the world

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Marincola, Francesco M ^a,b   Sheikh, Javaid I ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPLIED RESEARCH; ARTICLE; BASIC RESEARCH; BIOTECHNOLOGY; ECONOMIC ASPECT; EXPERIMENTAL RESEARCH; HEALTH CARE DELIVERY; HEALTH STATUS; HUMAN; INTELLECT; KNOWLEDGE; LEADERSHIP; MEDICINE; POLITICS; QATAR; RESEARCH; STANDARD; TRANSLATIONAL MEDICINE; WELLBEING;

COOPERATIVE BEHAVIOR; GREAT BRITAIN; HUMANS; PRIVATE SECTOR; PUBLIC SECTOR; QATAR; STATE MEDICINE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84865426980     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-177     Document Type: Article

References (71)

1. Lindahl S, Marincola FM. Translational medicine. Encyclopedia Britannica 2012, 2012:2012. in press.
2. Marincola FM. Translational medicine: a two way road. J Transl Med 2003, 1:1. 10.1186/1479-5876-1-1, 202357, 14527344.
3. Mankoff SP, Brander C, Ferrone S, Marincola FM. Lost in translation: obstacles to Translational Medicine. J Transl Med 2004, 2:14. 10.1186/1479-5876-2-14, 420261, 15149545.
4. Chouchane L, Mamtani R, Al-Thani MH, Al-Thani AA, Ameduri M, Sheikh JI. Medical education and research environment in Qatar: a new epoch for translational research in the Middle East. J Transl Med 2011, 9:16. 10.1186/1479-5876-9-16, 3038922, 21272322.
5. Moore CG, Carter RE, Nietert PJ, Stewart PW. Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci 2011, 4:332-337. 10.1111/j.1752-8062.2011.00347.x, 22029804.
6. Horig H, Marincola E, Marincola FM. Obstacles and opportunities in translational research. Nat Med 2005, 11:705-708. 10.1038/nm0705-705, 16015353.
7. Littman BH, Di Mario L, Plebani M, Marincola FM. What's next in Translational Medicine?. Clin Sci (Lond) 2007, 112:217-227.
8. Marincola FM. The trouble with translational medicine. J Intern Med 2011, 270:123-127. 10.1111/j.1365-2796.2011.02402.x, 21575085.
9. (Ed) Qatar National Research Fund - Funding Programs 2012, http://www.qnrf.org/funding_programs/nprp, (Ed).
10. (Ed) Qatar National Cancer Strategy 2012, http://www.nhsq.info/national-cancer-strategy, (Ed).
11. Galon J, Pages F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA. The Immune Score as a New Possible Approach for the Classification of Cancer. J Transl Med 2012, 10:1. 10.1186/1479-5876-10-1, 3269368, 22214470.
12. (Ed) Society for the Immunotherapy of Cancer - Immunoscore initiative 2012, http://www.sitcancer.org/about-sitc/initiatives/immunoscore, (Ed).
13. NCI Personalized Cancer Care/Drug Development Platform 2012, http://www.cancer.gov/aboutnci/recovery/recoveryfunding/personalized.
14. Emens LA, Silverstein SC, Khleif S, Marincola FM, Galon J. Toward integrative cancer immunotherapy: targeting the tumor microenvironment. J Transl Med 2012, 10:70. 10.1186/1479-5876-10-70, 3341195, 22490302.
15. Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011, 480:480-489. 10.1038/nature10673, 22193102.
16. Stroncek DF, Berger C, Cheever MA, Childs RW, Dudley ME, Flynn P, Gattinoni L, Heath JR, Kalos M, Marincola FM, et al. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med 2012, 10:48. 10.1186/1479-5876-10-48, 3362772, 22420641.
17. van der Burg SH, Melief CJ. Therapeutic vaccination against human papilloma virus induced malignancies. Curr Opin Immunol 2011, 23:252-257. 10.1016/j.coi.2010.12.010, 21237632.
18. Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM, Offringa R, Drijfhout JW, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 2009, 361:1838-1847. 10.1056/NEJMoa0810097, 19890126.
19. Brichard VG, Lejeune D. Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease. Expert Opin Biol Ther 2008, 8:951-968. 10.1517/14712598.8.7.951, 18549325.
20. Sonnett TE, Levien TL, Gates BJ, Robinson JD, Campbell RK. Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies. Ann Pharmacother 2010, 44:701-711. 10.1345/aph.1M640, 20233909.
21. Robinson GA, Geier M, Rizzolo D, Sedrak M. Childhood obesity: complications, prevention strategies, treatment. JAAPA 2011, 24:58-63.
22. Peterlik M. Vitamin D insufficiency and chronic diseases: Hype and reality. Food Funct 2012, 3:784-794. 10.1039/c2fo10262e, 22695493.
23. Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T, Brouckaert O, Peuteman G, Laenen A, Verlinden L, et al. Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome and genetic determinants of vitamin D insufficiency. Carcinogenesis 2012, 33:1319-1326. 10.1093/carcin/bgs187, 22623648.
24. Laleye LC, Kerkadi AH, Wasesa AA, Rao MV, Aboubacar A. Assessment of vitamin D and vitamin A intake by female students at the United Arab Emirates University based on self-reported dietary and selected fortified food consumption. Int J Food Sci Nutr 2011, 62:370-376. 10.3109/09637486.2010.533159, 21126211.
25. (Ed) Qatar Census 2012, http://www.qsa.gov.qa/QatarCensus/Populations.aspx, (Ed).
26. (Ed) Consanguinity Statistics 2012, http://www.consang.net, (Ed).
27. Bittles AH, Black ML. Evolution in health and medicine Sackler colloquium: Consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A 2010, 107(Suppl 1):1779-1786. 2868287, 19805052.
28. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010, 42:105-116. 10.1038/ng.520, 3018764, 20081858.
29. Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, Saloranta C, Tuomi T, Groop L. Genetic prediction of future type 2 diabetes. PLoS Med 2005, 2:e345. 10.1371/journal.pmed.0020345, 1274281, 17570749.
30. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010, 42:579-589. 10.1038/ng.609, 3080658, 20581827.
31. Liede A, Malik IA, Aziz Z, Rios Pd PL, Kwan E, Narod SA. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 2002, 71:595-606. 10.1086/342506, 379195, 12181777.
32. Ismail J, Jafar TH, Jafary FH, White F, Faruqui AM, Chaturvedi N. Risk factors for non-fatal myocardial infarction in young South Asian adults. Heart 2004, 90:259-263. 10.1136/hrt.2003.013631, 1768096, 14966040.
33. Ley TJ, Rosenberg LE. Removing career obstacles for young physician-scientists - loan-repayment programs. N Engl J Med 2002, 346:368-372.
34. Ley TJ, Rosenberg LE. The physician-scientist career pipeline in 2005: build it, and they will come. JAMA 2005, 294:1343-1351. 10.1001/jama.294.11.1343, 16174692.
35. Hobin JA, Deschamps AM, Bockman R, Cohen S, Dechow P, Eng C, Galey W, Morris M, Prabhakar S, Raj U, et al. Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles. J Transl Med 2012, 10:72. 10.1186/1479-5876-10-72, 3419626, 22500917.
36. (Ed) University of San Diego Incubator 2012, http://www.utsandiego.com/news/2012/apr/16/ucsd-build-biotech-incubator/?print&page=all, (Ed).
37. (Ed) The Accelerator 2012, http://www.seattlepi.com/business/article/Accelerator-aims-to-lure-nurture-best-ideas-in-1115363php, (Ed).
38. Friedman TL. The World is flat 2005, Farrar, Straus & Giroux, New York, NY.
39. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011, 104:510-520. 10.1258/jrsm.2011.110180, 22179294.
40. Marincola FM. In support of descriptive studies: relevance to translational research. J Transl Med 2007, 5:21. 10.1186/1479-5876-5-21, 1871566, 17474987.
41. Nussenblatt RB, Marincola FM, Schechter AN. Translational medicine-doing it backwards. J Transl Med 2010, 8:12. 10.1186/1479-5876-8-12, 2831830, 20132543.
42. Fontanarosa PB, DeAngelis CD. Basic science and translational research in JAMA. JAMA 2002, 287:1728. 10.1001/jama.287.13.1728, 11926900.
43. Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, et al. Central challenges facing the national clinical research enterprise. JAMA 2003, 289:1278-1287. 10.1001/jama.289.10.1278, 12633190.
44. Fontanarosa PB, DeAngelis CD. Translational medical research. JAMA 2003, 289:2133. 10.1001/jama.289.16.2133, 12709473.
45. Crowley WF, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johnson SB, Dobs A, et al. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. JAMA 2004, 291:1120-1126. 10.1001/jama.291.9.1120, 14996782.
46. Ioannidis JP. Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Transl Med 2004, 2:5. 10.1186/1479-5876-2-5, 343300, 14754464.
47. Parks MR, Disis ML. Conflicts of interest in translational research. J Transl Med 2004, 2:28. 10.1186/1479-5876-2-28, 514574, 15301694.
48. Schechter AN, Perlman RL, Rettig RA. Editors' Introduction: Why is Revitalizing Clinical Research So Important, Yet So Difficult?. Perspect Biol Med 2004, 47:476-486. 10.1353/pbm.2004.0070, 15467172.
49. Snyderman R. The clinical researcher-an "emerging" species. JAMA 2004, 291:882-883. 10.1001/jama.291.7.882, 14970069.
50. Snyderman R. AAP Presidential Address: The AAP and the transformation of medicine. J Clin Invest 2004, 114:1169-1173. 522278, 15489965.
51. Webb CP, Pass HI. Translation research: from accurate diagnosis to appropriate treatment. J Transl Med 2004, 2:35. 10.1186/1479-5876-2-35, 524522, 15496233.
52. Cech TR. Fostering innovation and discovery in biomedical research. JAMA 2005, 294:1390-1393. 10.1001/jama.294.11.1390, 16174699.
53. Cohen JJ, Siegel EK. Academic medical centers and medical research: the challenges ahead. JAMA 2005, 294:1367-1372. 10.1001/jama.294.11.1367, 16174695.
54. Fontanarosa PB, DeAngelis CD, Hunt N. Medical research-state of the science. JAMA 2005, 294:1424-1425. 10.1001/jama.294.11.1424, 16174710.
55. Moses H, Dorsey ER, Matheson DH, Thier SO. Financial anatomy of biomedical research. JAMA 2005, 294:1333-1342. 10.1001/jama.294.11.1333, 16174691.
56. Moskowitz J. A not so modest proposal for sustaining the american clinical research enterprise. J Surg Res 2005, 125:117-120. 10.1016/j.jss.2005.02.014, 15836860.
57. Zerhouni EA. US biomedical research: basic, translational, and clinical sciences. JAMA 2005, 294:1352-1358. 10.1001/jama.294.11.1352, 16174693.
58. Wehling M. Translational medicine: science or wishful thinking?. J Transl Med 2008, 6:31. 10.1186/1479-5876-6-31, 2442586, 18559092.
59. Albani S, Prakken B. The advancement of translational medicine-from regional challenges to global solutions. Nat Med 2009, 15:1006-1009. 10.1038/nm0909-1006, 19734876.
60. Collins F. The bridge between lab and clinic. Interview by Meredith Wadman. Nature 2010, 468:877. 10.1038/468877a, 21164451.
61. Fang FC, Casadevall A. Lost in translation-basic science in the era of translational research. Infect Immun 2010, 78:563-566. 10.1128/IAI.01318-09, 2812192, 20038540.
62. Sarkar IN. Biomedical informatics and translational medicine. J Transl Med 2010, 8:22. 10.1186/1479-5876-8-22, 2837642, 20187952.
63. Collins FS. Reengineering translational science: the time is right. Sci Transl Med 2011, 3:90. cm17.
64. Drolet BC, Lorenzi NM. Translational research: understanding the continuum from bench to bedside. Transl Res 2011, 157:1-5. 10.1016/j.trsl.2010.10.002, 21146144.
65. Sade RM. From laboratory to bedside: ethical, legal and social issues in translational research. Am J Med Sci 2011, 342:265-266. 10.1097/MAJ.0b013e318227deb1, 21952173.
66. Mintzberg H. Organizational design, fashion or fit?. Harvard Business Rev 1981, 59:103-116.
67. Young NS, Ioannidis JP, Al-Ubaydli O. Why current publication practices may distort science. PLoS Med 2008, 5:e201. 10.1371/journal.pmed.0050201, 2561077, 18844432.
68. (Ed) Science Exchange 2012, http://blog.scienceexchange.com/2012/04/how-can-core-facilities-better-connect-with-the-researchers-who-need-them, (Ed).
69. Carter RE, Woolson RF. Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside. J Transl Med 2004, 2:37. 10.1186/1479-5876-2-37, 527875, 15511289.
70. Belardelli F, Rizza P, Moretti F, Carella C, Galli MC, Migliaccio G. Translational research on advanced therapies. Ann Ist Super Sanita 2011, 47:72-78.
71. Fasolo A, Sessa C. Translational research in phase I trials. Clin Transl Oncol 2009, 11:580-588. 10.1007/s12094-009-0408-9, 19775997.